Genetic factor may influence measles infections. Those may include height susceptibility or resistance. Also the immune reaction to vaccination may be affected.
1. |
Xiang L et al. (1999) Quantitative alleles of CR1: coding sequence analysis and comparison of haplotypes in two ethnic groups. |
2. |
Warwicker P et al. (1998) Genetic studies into inherited and sporadic hemolytic uremic syndrome. |
3. |
Santoro F et al. (1999) CD46 is a cellular receptor for human herpesvirus 6. |
4. |
Tatsuo H et al. (2000) SLAM (CDw150) is a cellular receptor for measles virus. |
5. |
Källström H et al. (2001) Attachment of Neisseria gonorrhoeae to the cellular pilus receptor CD46: identification of domains important for bacterial adherence. |
6. |
Marie JC et al. (2002) Linking innate and acquired immunity: divergent role of CD46 cytoplasmic domains in T cell induced inflammation. |
7. |
Kemper C et al. (2003) Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype. |
8. |
Schneider-Schaulies J et al. (2003) Measles infection of the central nervous system. |
9. |
Johansson L et al. (2003) CD46 in meningococcal disease. |
10. |
Richards A et al. (2003) Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome. |
11. |
Gaggar A et al. (2003) CD46 is a cellular receptor for group B adenoviruses. |
12. |
Noris M et al. (2003) Familial haemolytic uraemic syndrome and an MCP mutation. |
15. |
Gaggar A et al. (2005) Localization of regions in CD46 that interact with adenovirus. |
16. |
Cassiani-Ingoni R et al. (2005) CD46 on glial cells can function as a receptor for viral glycoprotein-mediated cell-cell fusion. |
17. |
Yanagi Y et al. (2006) Measles virus receptors and tropism. |
19. |
Sood R et al. (2006) Gene expression patterns in human placenta. |
20. |
Caprioli J et al. (2006) Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome. |
21. |
Yanagi Y et al. (2006) Measles virus: cellular receptors, tropism and pathogenesis. |
23. |
Oliaro J et al. (2006) Ligation of the cell surface receptor, CD46, alters T cell polarity and response to antigen presentation. |
24. |
Karosi T et al. (2008) Disease-associated novel CD46 splicing variants and pathologic bone remodeling in otosclerosis. |
25. |
Yanagi Y et al. (2009) Measles virus receptors. |
26. |
Kemper C et al. (2009) Measles virus and CD46. |
27. |
Purcell DF et al. (1991) Identification of four different CD46 (MCP) molecules with anti-peptide antibodies. |
28. |
Santiago C et al. (2010) Structure of the measles virus hemagglutinin bound to the CD46 receptor. |
29. |
Haralambieva IH et al. (2011) Genetic polymorphisms in host antiviral genes: associations with humoral and cellular immunity to measles vaccine. |
31. |
Andrews PW et al. (1985) A human cell-surface antigen defined by a monoclonal antibody and controlled by a gene on human chromosome 1. |
32. |
Bora NS et al. (1989) Structural gene for human membrane cofactor protein (MCP) of complement maps to within 100 kb of the 3' end of the C3b/C4b receptor gene. |
33. |
Lublin DM et al. (1988) Molecular cloning and chromosomal localization of human membrane cofactor protein (MCP). Evidence for inclusion in the multigene family of complement-regulatory proteins. |
34. |
Pirson Y et al. (1987) Hemolytic uremic syndrome in three adult siblings: a familial study and evolution. |
35. |
McIntyre JA et al. (1983) Human trophoblast-lymphocyte cross-reactive (TLX) antigens define a new alloantigen system. |
37. |
Dörig RE et al. (1993) The human CD46 molecule is a receptor for measles virus (Edmonston strain). |
38. |
Källström H et al. (1997) Membrane cofactor protein (MCP or CD46) is a cellular pilus receptor for pathogenic Neisseria. |
39. |
Teles RM et al. (2013) Type I interferon suppresses type II interferon-triggered human anti-mycobacterial responses. |
40. |
Fields PE et al. (2002) Cutting edge: changes in histone acetylation at the IL-4 and IFN-gamma loci accompany Th1/Th2 differentiation. |
41. |
Wathelet MG et al. (1988) Cloning and chromosomal location of human genes inducible by type I interferon. |
42. |
Bass BL et al. (1988) An unwinding activity that covalently modifies its double-stranded RNA substrate. |
43. |
Wang Y et al. (1995) Genomic organization and chromosomal location of the human dsRNA adenosine deaminase gene: the enzyme for glutamate-activated ion channel RNA editing. |
44. |
Patterson JB et al. (1995) Expression and regulation by interferon of a double-stranded-RNA-specific adenosine deaminase from human cells: evidence for two forms of the deaminase. |
45. |
O'Connell MA et al. (1995) Cloning of cDNAs encoding mammalian double-stranded RNA-specific adenosine deaminase. |
46. |
Kim U et al. (1994) Molecular cloning of cDNA for double-stranded RNA adenosine deaminase, a candidate enzyme for nuclear RNA editing. |
47. |
Weier HU et al. (1995) The interferon-inducible, double-stranded RNA-specific adenosine deaminase gene (DSRAD) maps to human chromosome 1q21.1-21.2. |
48. |
Weier HU et al. (2000) Assignment of the RNA-specific adenosine deaminase gene (Adar) to mouse chromosome 3F2 by in situ hybridization. |
49. |
Wang Q et al. (2000) Requirement of the RNA editing deaminase ADAR1 gene for embryonic erythropoiesis. |
50. |
Herbert A et al. (2002) Induction of protein translation by ADAR1 within living cell nuclei is not dependent on RNA editing. |
51. |
Miyamura Y et al. (2003) Mutations of the RNA-specific adenosine deaminase gene (DSRAD) are involved in dyschromatosis symmetrica hereditaria. |
52. |
Tojo K et al. (2006) Dystonia, mental deterioration, and dyschromatosis symmetrica hereditaria in a family with ADAR1 mutation. |
53. |
Chao SC et al. () A novel nonsense mutation of the DSRAD gene in a Taiwanese family with dyschromatosis symmetrica hereditaria. |
54. |
Xing Q et al. () Novel deletion mutation of DSRAD in a Chinese family with Dyschromatosis Symmetrica Hereditaria (DSH). |
55. |
Agranat L et al. (2008) The editing enzyme ADAR1 and the mRNA surveillance protein hUpf1 interact in the cell nucleus. |
56. |
Rice GI et al. (2012) Mutations in ADAR1 cause Aicardi-Goutières syndrome associated with a type I interferon signature. |
57. |
Justice MJ et al. (1990) A genetic linkage map of mouse chromosome 10: localization of eighteen molecular markers using a single interspecific backcross. |
58. |
None (1977) The status of interferon. |
59. |
Creagan RP et al. (1975) Somatic cell genetic analysis of the interferon system. |
60. |
Shimizu A et al. (1992) A molecular genetic linkage map of mouse chromosome 10, including the Myb, S100b, Pah, Sl, and Ifg genes. |
61. |
Tzoneva M et al. (1988) Selective immunodeficiency with defect in interferon-gamma induction in two sibs with recurrent infections. |
62. |
Luster AD et al. () Gamma-interferon transcriptionally regulates an early-response gene containing homology to platelet proteins. |
63. |
Lipinski M et al. (1980) Natural killer and killer cell activities in patients with primary immunodeficiencies or defects in immune interferon production. |
64. |
Mantei N et al. (1980) The nucleotide sequence of a cloned human leukocyte interferon cDNA. |
65. |
Blalock JE et al. (1980) Human leukocyte interferon: structural and biological relatedness to adrenocorticotropic hormone and endorphins. |
66. |
Maeda S et al. (1980) Construction and identification of bacterial plasmids containing nucleotide sequence for human leukocyte interferon. |
67. |
Devos R et al. (1982) Molecular cloning of human immune interferon cDNA and its expression in eukaryotic cells. |
68. |
Yip YK et al. (1982) Purification of two subspecies of human gamma (immune) interferon. |
69. |
Gray PW et al. (1982) Structure of the human immune interferon gene. |
70. |
Naylor SL et al. (1983) Human immune interferon gene is located on chromosome 12. |
71. |
Nathan CF et al. (1983) Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. |
72. |
Trent JM et al. (1982) Chromosomal localization of human leukocyte, fibroblast, and immune interferon genes by means of in situ hybridization. |
73. |
Knight E et al. (1980) Human fibroblast interferon: amino acid analysis and amino terminal amino acid sequence. |
74. |
Zoon KC et al. (1980) Amino terminal sequence of the major component of human lymphoblastoid interferon. |
75. |
Zimonjic DB et al. (1995) Mapping of the immune interferon gamma gene (IFNG) to chromosome band 12q14 by fluorescence in situ hybridization. |
76. |
Bureau JF et al. (1995) The gene coding for interferon-gamma is linked to the D12S335 and D12S313 microsatellites and to the MDM2 gene. |
77. |
Diaz MO et al. (1993) Nomenclature of the human interferon genes. |
78. |
Tsubota K et al. (1999) Regulation of human leukocyte antigen expression in human conjunctival epithelium. |
79. |
Pravica V et al. (1999) In vitro production of IFN-gamma correlates with CA repeat polymorphism in the human IFN-gamma gene. |
80. |
Diefenbach A et al. (1999) Requirement for type 2 NO synthase for IL-12 signaling in innate immunity. |
81. |
Awad M et al. (1999) CA repeat allele polymorphism in the first intron of the human interferon-gamma gene is associated with lung allograft fibrosis. |
82. |
Bream JH et al. (2000) Polymorphisms of the human IFNG gene noncoding regions. |
83. |
White AC et al. (2000) Interferon-gamma expression in jejunal biopsies in experimental human cryptosporidiosis correlates with prior sensitization and control of oocyst excretion. |
84. |
Khani-Hanjani A et al. (2000) Association between dinucleotide repeat in non-coding region of interferon-gamma gene and susceptibility to, and severity of, rheumatoid arthritis. |
86. |
Badovinac VP et al. (2000) Regulation of antigen-specific CD8+ T cell homeostasis by perforin and interferon-gamma. |
87. |
Takayanagi H et al. (2000) T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma. |
88. |
Zohlnhöfer D et al. (2001) Transcriptome analysis reveals a role of interferon-gamma in human neointima formation. |
89. |
Binder GK et al. (2001) Interferon-gamma-mediated site-specific clearance of alphavirus from CNS neurons. |
90. |
Cavet J et al. (2001) Interferon-gamma and interleukin-6 gene polymorphisms associate with graft-versus-host disease in HLA-matched sibling bone marrow transplantation. |
91. |
Szabo SJ et al. (2002) Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells. |
92. |
Ben-Asouli Y et al. (2002) Human interferon-gamma mRNA autoregulates its translation through a pseudoknot that activates the interferon-inducible protein kinase PKR. |
93. |
Dabora SL et al. (2002) Association between a high-expressing interferon-gamma allele and a lower frequency of kidney angiomyolipomas in TSC2 patients. |
94. |
Messi M et al. (2003) Memory and flexibility of cytokine gene expression as separable properties of human T(H)1 and T(H)2 lymphocytes. |
95. |
Rossouw M et al. (2003) Association between tuberculosis and a polymorphic NFkappaB binding site in the interferon gamma gene. |
96. |
An P et al. (2003) A tumor necrosis factor-alpha-inducible promoter variant of interferon-gamma accelerates CD4+ T cell depletion in human immunodeficiency virus-1-infected individuals. |
97. |
Dufour C et al. (2004) Homozygosis for (12) CA repeats in the first intron of the human IFN-gamma gene is significantly associated with the risk of aplastic anaemia in Caucasian population. |
98. |
Koh KP et al. (2004) T cell-mediated vascular dysfunction of human allografts results from IFN-gamma dysregulation of NO synthase. |
99. |
Spilianakis CG et al. (2005) Interchromosomal associations between alternatively expressed loci. |
100. |
Chang S et al. (2005) Histone hyperacetylated domains across the Ifng gene region in natural killer cells and T cells. |
101. |
Cooke GS et al. (2006) Polymorphism within the interferon-gamma/receptor complex is associated with pulmonary tuberculosis. |
102. |
Huang Y et al. (2007) A functional SNP of interferon-gamma gene is important for interferon-alpha-induced and spontaneous recovery from hepatitis C virus infection. |
103. |
Barton ES et al. (2007) Herpesvirus latency confers symbiotic protection from bacterial infection. |
104. |
Schoenborn JR et al. (2007) Regulation of interferon-gamma during innate and adaptive immune responses. |
105. |
Kosaka H et al. (2008) Interferon-gamma is a therapeutic target molecule for prevention of postoperative adhesion formation. |
106. |
Pacheco AG et al. (2008) IFNG +874T/A, IL10 -1082G/A and TNF -308G/A polymorphisms in association with tuberculosis susceptibility: a meta-analysis study. |
107. |
King VL et al. (2009) Interferon-gamma and the interferon-inducible chemokine CXCL10 protect against aneurysm formation and rupture. |
108. |
Baldridge MT et al. (2010) Quiescent haematopoietic stem cells are activated by IFN-gamma in response to chronic infection. |
109. |
Zaidi MR et al. (2011) Interferon-γ links ultraviolet radiation to melanomagenesis in mice. |
110. |
Zielinski CE et al. (2012) Pathogen-induced human TH17 cells produce IFN-γ or IL-10 and are regulated by IL-1β. |
111. |
Braumüller H et al. (2013) T-helper-1-cell cytokines drive cancer into senescence. |
112. |
Webb GC et al. (1990) Mapping the gene for murine T-cell growth factor, Il-2, to bands B-C on chromosome 3 and for the alpha chain of the IL2-receptor, Il-2ra, to bands A2-A3 on chromosome 2. |
113. |
Leonard WJ et al. (1985) Localization of the gene encoding the human interleukin-2 receptor on chromosome 10. |
114. |
Rickert M et al. (2005) The structure of interleukin-2 complexed with its alpha receptor. |
115. |
Wang X et al. (2005) Structure of the quaternary complex of interleukin-2 with its alpha, beta, and gammac receptors. |
116. |
Li K et al. (2005) Distinct poly(I-C) and virus-activated signaling pathways leading to interferon-beta production in hepatocytes. |
117. |
Bigham AW et al. (2011) Host genetic risk factors for West Nile virus infection and disease progression. |
118. |
Kato H et al. (2006) Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. |
119. |
Imaizumi T et al. (2002) Retinoic acid-inducible gene-I is induced in endothelial cells by LPS and regulates expression of COX-2. |
120. |
Cui XF et al. (2004) Retinoic acid-inducible gene-I is induced by interferon-gamma and regulates the expression of interferon-gamma stimulated gene 15 in MCF-7 cells. |
121. |
Yoneyama M et al. (2004) The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. |
122. |
Imaizumi T et al. (2004) Expression of retinoic acid-inducible gene-I in vascular smooth muscle cells stimulated with interferon-gamma. |
123. |
Imaizumi T et al. () Interferon-gamma induces retinoic acid-inducible gene-I in endothelial cells. |
124. |
Breiman A et al. (2005) Inhibition of RIG-I-dependent signaling to the interferon pathway during hepatitis C virus expression and restoration of signaling by IKKepsilon. |
125. |
Kato H et al. (2005) Cell type-specific involvement of RIG-I in antiviral response. |
126. |
Pichlmair A et al. (2006) RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates. |
127. |
Hornung V et al. (2006) 5'-Triphosphate RNA is the ligand for RIG-I. |
128. |
Saito T et al. (2007) Regulation of innate antiviral defenses through a shared repressor domain in RIG-I and LGP2. |
129. |
Gack MU et al. (2007) TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. |
130. |
Arimoto K et al. (2007) Negative regulation of the RIG-I signaling by the ubiquitin ligase RNF125. |
131. |
Zhang NN et al. (2008) RIG-I plays a critical role in negatively regulating granulocytic proliferation. |
132. |
Myong S et al. (2009) Cytosolic viral sensor RIG-I is a 5'-triphosphate-dependent translocase on double-stranded RNA. |
133. |
Oshiumi H et al. (2010) The ubiquitin ligase Riplet is essential for RIG-I-dependent innate immune responses to RNA virus infection. |
134. |
Kok KH et al. (2011) The double-stranded RNA-binding protein PACT functions as a cellular activator of RIG-I to facilitate innate antiviral response. |
135. |
Jiang F et al. (2011) Structural basis of RNA recognition and activation by innate immune receptor RIG-I. |
136. |
Lyons PA et al. (2000) Congenic mapping of the type 1 diabetes locus, Idd3, to a 780-kb region of mouse chromosome 3: identification of a candidate segment of ancestral DNA by haplotype mapping. |
137. |
Ku CC et al. (2000) Control of homeostasis of CD8+ memory T cells by opposing cytokines. |
138. |
Ghosh A et al. (2001) A specific isozyme of 2'-5' oligoadenylate synthetase is a dual function proapoptotic protein of the Bcl-2 family. |
139. |
Gebert B et al. (2003) Helicobacter pylori vacuolating cytotoxin inhibits T lymphocyte activation. |
140. |
Ferlazzo G et al. (2004) The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic. |
141. |
King C et al. (2004) Homeostatic expansion of T cells during immune insufficiency generates autoimmunity. |
143. |
Field LL et al. (2005) OAS1 splice site polymorphism controlling antiviral enzyme activity influences susceptibility to type 1 diabetes. |
144. |
Williams MA et al. (2006) Interleukin-2 signals during priming are required for secondary expansion of CD8+ memory T cells. |
145. |
Rutherford MN et al. (1991) The murine 2-5A synthetase locus: three distinct transcripts from two linked genes. |
146. |
Yamanouchi J et al. (2007) Interleukin-2 gene variation impairs regulatory T cell function and causes autoimmunity. |
147. |
Lim JK et al. (2009) Genetic variation in OAS1 is a risk factor for initial infection with West Nile virus in man. |
148. |
Weinberg K et al. (1990) Severe combined immunodeficiency due to a specific defect in the production of interleukin-2. |
149. |
Benech P et al. (1985) Structure of two forms of the interferon-induced (2'-5') oligo A synthetase of human cells based on cDNAs and gene sequences. |
150. |
Williams BR et al. (1986) Interferon-regulated human 2-5A synthetase gene maps to chromosome 12. |
151. |
Bonnevie-Nielsen V et al. (1989) Association of IDDM and attenuated response of 2',5'-oligoadenylate synthetase to yellow fever vaccine. |
152. |
Fiorentino L et al. (1989) Assignment of the interleukin-2 locus to mouse chromosome 3. |
153. |
Smith KA et al. (1985) Interleukin 2 regulates its own receptors. |
154. |
Depper JM et al. (1985) Interleukin 2 (IL-2) augments transcription of the IL-2 receptor gene. |
155. |
Greene WC et al. (1986) The human interleukin-2 receptor. |
156. |
None (1988) Interleukin-2: inception, impact, and implications. |
157. |
Wathelet M et al. (1986) Full-length sequence and expression of the 42 kDa 2-5A synthetase induced by human interferon. |
158. |
Lowenthal JW et al. () Similarities between interleukin-2 receptor number and affinity on activated B and T lymphocytes. |
159. |
Clark SC et al. (1984) Human T-cell growth factor: partial amino acid sequence, cDNA cloning, and organization and expression in normal and leukemic cells. |
160. |
Seigel LJ et al. (1984) Gene for T-cell growth factor: location on human chromosome 4q and feline chromosome B1. |
161. |
Degrave W et al. (1983) Cloning and structure of the human interleukin 2 chromosomal gene. |
162. |
Fujita T et al. (1983) Structure of the human interleukin 2 gene. |
163. |
Merlin G et al. (1983) Molecular cloning and sequence of partial cDNA for interferon-induced (2'-5')oligo(A) synthetase mRNA from human cells. |
164. |
Rosenberg SA et al. (1984) Biological activity of recombinant human interleukin-2 produced in Escherichia coli. |
165. |
Taniguchi T et al. () Structure and expression of a cloned cDNA for human interleukin-2. |
166. |
Cantrell DA et al. (1984) The interleukin-2 T-cell system: a new cell growth model. |
167. |
Stern AS et al. (1984) Purification to homogeneity and partial characterization of interleukin 2 from a human T-cell leukemia. |
168. |
Holbrook NJ et al. (1984) T-cell growth factor: complete nucleotide sequence and organization of the gene in normal and malignant cells. |
169. |
Shows T et al. (1984) Interleukin 2 (IL2) is assigned to human chromosome 4. |
170. |
Holländer GA et al. (1998) Monoallelic expression of the interleukin-2 locus. |
171. |
Hovnanian A et al. (1998) The human 2',5'-oligoadenylate synthetase locus is composed of three distinct genes clustered on chromosome 12q24.2 encoding the 100-, 69-, and 40-kDa forms. |
172. |
OMIM.ORG article Omim 120920 |